Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Neurorehabil Neural Repair. 2015 May 15;30(1):83–93. doi: 10.1177/1545968315586465

Figure 2.

Figure 2

GOS was sub-divided as favorable (4-5) and unfavorable (2-3) for analyses with BDNF levels. (A) At 6 months, weekly averages of CSF were significantly higher in subjects who died compared to subjects who survived (both favorable and unfavorable outcomes, p<0.05). At 12 months, GOS levels were significantly different between subjects who died and subjects with favorable outcomes (p<0.05). (B) Weekly serum levels tended to be lower in subjects who died by 12 months compared to subjects who had favorable outcomes (p=0.051), but there was no significant association at 6 months.